Jaguar Health, Inc.

US$0.40As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:JAGXHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (91.77%)
Div yield —
ROE (548.83%)
Biotechnology
Beta (5Y) (0.12)
PE TTM —
TSR TTM (99.96%)
Mkt cap US$0.210M
ROIC (51.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.438
8.33%
193.60%
Hold 11|12|6|1|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
7.07%
11.97%
21.82%
4.04%
Revenue$M
0.017
0.017
0.017
0.018
0.81%
(3.76%)
(3.07%)
4.03%
Peers (US$0.210M)
Cap (US$)
PE
0.453M
—
0.074M
—
0.243M
—
Capital
TTM
5Y
10Y
Leveragex
1.907
(0.105)
(0.094)
EBIT/Intx
0.481
0.405
0.296
Own earn%
209.98
(11.18)
(11.34)
Sh yield%
46.40
21.36
21.44
Owners
Insiders/Inst%
6.33
33.57
Short interest%
2.95
SBC / revenue%
3.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–3
$1 testx
−1.2
Incr. ROIC%
3